Amiodarone for refractory atrial fibrillation

Robert L. Gold, Charles I. Haffajee, George Charos, Kathy Sloan, Stephen Baker, Joseph S Alpert

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

Atrial fibrilation (AF) is a difficult arrhythmia to manage with antiarrhythmic agents. Amiodarone is highly effective in restoring and maintaining normal sinus rhythm in patients with AF. However, the mechanism and predictors of efficacy for amiodarone in treating AF have not been adequately addressed. Various measures of success or failure of amiodarone therapy were examined in 68 patients who had paroxysmal or chronic, established AF refractory to conventional antiarrhythmic agents. The patients were 25 to 75 years old (mean 59) and mean follow-up was 21 months (range 3 to 56). Maintenance amiodarone dosages were 200 to 400 mg/day. Overall, amiodarone therapy was effective long term in 54 of the 68 patients (79%). Left atrial diameter, age, gender and origin of AF were not helpful in predicting success or failure of amiodarone therapy. The presence of chronic AF for longer than 1 year was an adverse factor in maintaining normal sinus rhythm (p = 0.007), although the success rate even in this group was relatively high (57%). Thirty-five percent of the patients had adverse effects, which precluded long-term therapy with amiodarone in 10%.

Original languageEnglish (US)
Pages (from-to)124-127
Number of pages4
JournalThe American journal of cardiology
Volume57
Issue number1
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Amiodarone
Atrial Fibrillation
Therapeutics
Cardiac Arrhythmias
Maintenance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Amiodarone for refractory atrial fibrillation. / Gold, Robert L.; Haffajee, Charles I.; Charos, George; Sloan, Kathy; Baker, Stephen; Alpert, Joseph S.

In: The American journal of cardiology, Vol. 57, No. 1, 01.01.1986, p. 124-127.

Research output: Contribution to journalArticle

Gold, RL, Haffajee, CI, Charos, G, Sloan, K, Baker, S & Alpert, JS 1986, 'Amiodarone for refractory atrial fibrillation', The American journal of cardiology, vol. 57, no. 1, pp. 124-127. https://doi.org/10.1016/0002-9149(86)90964-1
Gold, Robert L. ; Haffajee, Charles I. ; Charos, George ; Sloan, Kathy ; Baker, Stephen ; Alpert, Joseph S. / Amiodarone for refractory atrial fibrillation. In: The American journal of cardiology. 1986 ; Vol. 57, No. 1. pp. 124-127.
@article{1f46582b813b48aa9674c03c484e8bf8,
title = "Amiodarone for refractory atrial fibrillation",
abstract = "Atrial fibrilation (AF) is a difficult arrhythmia to manage with antiarrhythmic agents. Amiodarone is highly effective in restoring and maintaining normal sinus rhythm in patients with AF. However, the mechanism and predictors of efficacy for amiodarone in treating AF have not been adequately addressed. Various measures of success or failure of amiodarone therapy were examined in 68 patients who had paroxysmal or chronic, established AF refractory to conventional antiarrhythmic agents. The patients were 25 to 75 years old (mean 59) and mean follow-up was 21 months (range 3 to 56). Maintenance amiodarone dosages were 200 to 400 mg/day. Overall, amiodarone therapy was effective long term in 54 of the 68 patients (79{\%}). Left atrial diameter, age, gender and origin of AF were not helpful in predicting success or failure of amiodarone therapy. The presence of chronic AF for longer than 1 year was an adverse factor in maintaining normal sinus rhythm (p = 0.007), although the success rate even in this group was relatively high (57{\%}). Thirty-five percent of the patients had adverse effects, which precluded long-term therapy with amiodarone in 10{\%}.",
author = "Gold, {Robert L.} and Haffajee, {Charles I.} and George Charos and Kathy Sloan and Stephen Baker and Alpert, {Joseph S}",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0002-9149(86)90964-1",
language = "English (US)",
volume = "57",
pages = "124--127",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Amiodarone for refractory atrial fibrillation

AU - Gold, Robert L.

AU - Haffajee, Charles I.

AU - Charos, George

AU - Sloan, Kathy

AU - Baker, Stephen

AU - Alpert, Joseph S

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Atrial fibrilation (AF) is a difficult arrhythmia to manage with antiarrhythmic agents. Amiodarone is highly effective in restoring and maintaining normal sinus rhythm in patients with AF. However, the mechanism and predictors of efficacy for amiodarone in treating AF have not been adequately addressed. Various measures of success or failure of amiodarone therapy were examined in 68 patients who had paroxysmal or chronic, established AF refractory to conventional antiarrhythmic agents. The patients were 25 to 75 years old (mean 59) and mean follow-up was 21 months (range 3 to 56). Maintenance amiodarone dosages were 200 to 400 mg/day. Overall, amiodarone therapy was effective long term in 54 of the 68 patients (79%). Left atrial diameter, age, gender and origin of AF were not helpful in predicting success or failure of amiodarone therapy. The presence of chronic AF for longer than 1 year was an adverse factor in maintaining normal sinus rhythm (p = 0.007), although the success rate even in this group was relatively high (57%). Thirty-five percent of the patients had adverse effects, which precluded long-term therapy with amiodarone in 10%.

AB - Atrial fibrilation (AF) is a difficult arrhythmia to manage with antiarrhythmic agents. Amiodarone is highly effective in restoring and maintaining normal sinus rhythm in patients with AF. However, the mechanism and predictors of efficacy for amiodarone in treating AF have not been adequately addressed. Various measures of success or failure of amiodarone therapy were examined in 68 patients who had paroxysmal or chronic, established AF refractory to conventional antiarrhythmic agents. The patients were 25 to 75 years old (mean 59) and mean follow-up was 21 months (range 3 to 56). Maintenance amiodarone dosages were 200 to 400 mg/day. Overall, amiodarone therapy was effective long term in 54 of the 68 patients (79%). Left atrial diameter, age, gender and origin of AF were not helpful in predicting success or failure of amiodarone therapy. The presence of chronic AF for longer than 1 year was an adverse factor in maintaining normal sinus rhythm (p = 0.007), although the success rate even in this group was relatively high (57%). Thirty-five percent of the patients had adverse effects, which precluded long-term therapy with amiodarone in 10%.

UR - http://www.scopus.com/inward/record.url?scp=0022632760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022632760&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(86)90964-1

DO - 10.1016/0002-9149(86)90964-1

M3 - Article

C2 - 3942054

AN - SCOPUS:0022632760

VL - 57

SP - 124

EP - 127

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -